Literature DB >> 32281334

[Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19)].

Zhi-Jian Lin1, Bing Zhang1.   

Abstract

The outbreak of coronavirus disease 2019(COVID-19) seriously endangers people's health. Traditional Chinese medicine(TCM) has been recommended for the treatment of COVID-19 in Novel Coronavirus Pneumonia Prevention and Control Strategy, which have made outstanding contributions to the prevention and control of the epidemic. The wide application of Chinese medicine asked the pharmacists and doctors, nurses, and medical technicians in Wuhan and around the country to stand on the front line of COVID-19 treatment, and provide pharmaceutical care services, which has effectively guaranteed the safety and rational use of Chinese medicine. This article will introduce the TCM cognition of the COVID-19, analyze the clinical application of Chinese medicine and the entry point of pharmaceutical care, and clarify that clinical Chinese pharmacists can participate in making medication therapy plan, medication reconciliation, and prescription review, promoting rational drug use, pharmaceutical monitoring, and drug risk management. The participation of clinical Chinese pharmacists in the prevention and treatment of COVID-19 is conducive to improving the level of rational use of TCM, by ensuring the effectiveness, and safety.

Entities:  

Keywords:  2019-nCoV; clinical Chinese pharmacist; coronavirus disease 2019(COVID-19); pharmaceutical care; phasmaceutical mornitoring; traditional Chinese medicine

Mesh:

Year:  2020        PMID: 32281334     DOI: 10.19540/j.cnki.cjcmm.20200211.501

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Mapping Evidence of Pharmacy Services for COVID-19 in China.

Authors:  Zhan-Miao Yi; Yang Hu; Guan-Ru Wang; Rong-Sheng Zhao
Journal:  Front Pharmacol       Date:  2020-10-02       Impact factor: 5.810

2.  Role of pharmacists during the COVID-19 pandemic in China-Shanghai experiences.

Authors:  Yun Liao; Chunlai Ma; Alan H Lau; Mingkang Zhong
Journal:  J Am Coll Clin Pharm       Date:  2020-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.